Farmacocinética, Nanotecnología y Terapia Génica (PharmaNanoGene) - GIC 21/034
Hospital de Galdakao - Usansolo
Galdácano, EspañaPublicaciones en colaboración con investigadoras/es de Hospital de Galdakao - Usansolo (11)
2017
-
Hiccups in Parkinson’s disease: an analysis of cases reported in the European pharmacovigilance database and a review of the literature
European Journal of Clinical Pharmacology, Vol. 73, Núm. 9, pp. 1159-1164
2015
-
Adverse reactions to antipsychotics in parkinson disease: An analysis of the Spanish Pharmacovigilance database
Clinical Neuropharmacology, Vol. 38, Núm. 3, pp. 69-84
-
Anticholinergic burden in Parkinson's disease inpatients
European Journal of Clinical Pharmacology, Vol. 71, Núm. 10, pp. 1271-1277
2014
-
Desafíos en el manejo farmacoterapéutico del paciente ingresado con enfermedad de Parkinson
Revista de Neurologia, Vol. 58, Núm. 8, pp. 353-364
2005
-
Bicompartmental kinetics of tobramycin analysed with a wide range of covariates
International Journal of Antimicrobial Agents, Vol. 26, Núm. 4, pp. 304-311
2004
-
Influence of formulation on propofol pharmacokinetics and pharmacodynamics in anesthetized patients
Acta Anaesthesiologica Scandinavica, Vol. 48, Núm. 8, pp. 1038-1048
1998
-
The significance of lipoproteins in serum binding variations of propofol
Anesthesia and Analgesia, Vol. 87, Núm. 5, pp. 1147-1151
1997
-
Serum protein binding of propofol in critically ill patients
Acta Anaesthesiologica Scandinavica, Vol. 41, Núm. 10, pp. 1267-1272
1996
-
DOCENCIA DE PREGRADO EN FARMACIA CLINICA: EXPERIENCIA DE LA UPV/EHU
Farmacia Clinica
1993
-
Influence of several surgical techniques in peptic ulcer disease on the oral kinetic of a basic drug.
Acta chirurgica Belgica, Vol. 93, Núm. 3, pp. 88-91
1989
-
Displacement of warfarin from human serum proteins by halothane anaesthesia
Acta Anaesthesiologica Scandinavica, Vol. 33, Núm. 7, pp. 575-577